Table of Content

1. Executive Summary


2. Introduction

2.1 Contract Development and Manufacturing Organization (CDMO): An Overview
2.1.1 CDMO Value Chain Overview

2.2 CDMO Segmentation: An Overview
2.2.1 CDMO Segmentation


3. Global Market Analysis

3.1 Global CDMO Market: An Analysis

3.1.1 Global Contract Development and Manufacturing Organization (CDMO) Market: An Overview
3.1.2 Global CDMO Market by Value
3.1.3 Global CDMO Market by Type (Chemical Drugs and Biologics)
3.1.4 Global CDMO Market by Product (API/Bulk Drugs, Drug Product Manufacturing (Inc. Dosage & Formulation Development) and Packaging)
3.1.5 Global CDMO Market by Sourcing (In House and Outsourced)
3.1.6 Global CDMO Market by Application (Oncology, Cardiovascular Disease, Diabetes, Hormonal, Glaucoma and Others)
3.1.7 Global CDMO Market by Region (North America, Europe, Asia Pacific, and Rest of the World (ROW))

3.2 Global CDMO Market: Type Analysis

3.2.1 Global CDMO Market By Type: An Overview
3.2.2 Global Chemical Drugs CDMO Market By Value
3.2.3 Global Biologics CDMO Market By Value

3.3 Global CDMO Market: Product Analysis

3.3.1 Global CDMO Market By Product: An Overview
3.3.2 Global API/Bulk Drugs CDMO Market By Value
3.3.3 Global Drug Product Manufacturing (Inc. Dosage & Formulation Development) CDMO Market By Value
3.3.4 Global Packaging CDMO Market By Value

3.4 Global CDMO Market: Sourcing Analysis

3.4.1 Global CDMO Market By Sourcing: An Overview
3.4.2 Global In House CDMO Market By Value
3.4.3 Global Outsourced CDMO Market By Value

3.5 Global CDMO Market: Application Analysis

3.5.1 Global CDMO Market By Application: An Overview
3.5.2 Global Oncology CDMO Market By Value
3.5.3 Global Cardiovascular Disease CDMO Market By Value
3.5.4 Global Diabetes CDMO Market By Value
3.5.5 Global Hormonal CDMO Market By Value
3.5.6 Global Glaucoma CDMO Market By Value
3.5.7 Global Other CDMO Applications Market By Value


4. Regional Market Analysis

4.1 Asia Pacific CDMO Market: An Analysis

4.1.1 Asia Pacific CDMO Market: An Overview
4.1.2 Asia Pacific CDMO Market by Value
4.1.3 Asia Pacific CDMO Market by Region (China, Japan, India, and Rest of Asia Pacific)
4.1.4 China CDMO Market by Value
4.1.5 China CDMO Market by Type (Chemical Drugs and Biologics)
4.1.6 China Chemical Drugs CDMO Market by Value
4.1.7 China Biologics CDMO Market by Value
4.1.8 Japan CDMO Market by Value
4.1.9 India CDMO Market by Value
4.1.10 Rest of Asia Pacific CDMO Market by Value

4.2 North America CDMO Market: An Analysis

4.2.1 North America CDMO Market: An Overview
4.2.2 North America CDMO Market by Value
4.2.3 North America CDMO Market by Region (the US, Canada and Mexico)
4.2.4 The US CDMO Market by Value
4.2.5 The US CDMO Market by Product (API/Bulk Drugs, Drug Product Manufacturing (Inc. Dosage & Formulation Development) and Packaging)
4.2.6 The US API/Bulk Drugs CDMO Market By Value
4.2.7 The US Drug Product Manufacturing (Inc. Dosage & Formulation Development) CDMO Market By Value
4.2.8 The US Packaging CDMO Market By Value
4.2.9 Canada CDMO Market by Value
4.2.10 Mexico CDMO Market by Value

4.3 Europe CDMO Market: An Analysis

4.3.1 Europe CDMO Market: An Overview
4.3.2 Europe CDMO Market by Value
4.3.3 Europe CDMO Market by Region (Germany, United Kingdom, France, and Rest of the Europe)
4.3.4 Germany CDMO Market by Value
4.3.5 United Kingdom CDMO Market by Value
4.3.6 France CDMO Market by Value
4.3.7 Rest of Europe CDMO Market by Value

4.4 Rest of the World CDMO Market: An Analysis

4.4.1 Rest of the World CDMO Market: An Overview
4.4.2 Rest of the World CDMO Market by Value


5. Impact of COVID-19

5.1 Impact of COVID-19
5.1.1 Surge in Contracts to CDMOs

5.2 Post-COVID Scenario


6. Market Dynamics

6.1 Growth Drivers
6.1.1 Aging Population
6.1.2 Rising Healthcare Expenditure
6.1.3 Increasing Pharmaceutical R&D Expenses
6.1.4 Escalating Demand for Active Pharmaceutical Ingredient (API)
6.1.5 Surge in Outsourcing Trends
6.1.6 Rising Prevalence of Genetic Disorders

6.2 Challenges
6.2.1 Biotech Funding Issues
6.2.2 Varying Regulatory Requirements Across Regions
6.2.3 Dependence on Patents, Copyrights, Trademarks and Trade Secrets

6.3 Market Trends
6.3.1 Growing Biologics Market
6.3.2 Rising Development of Small Molecule Drugs
6.3.3 Bringing Orphan Drugs to Market
6.3.4 Emerging Markets
6.3.5 Rise in Investments and Strategic Collaborations
6.3.6 Technological Advancement in the CDMO


7. Competitive Landscape

7.1 Global CDMO Market Players: Competitive Landscape
7.2 Global Biologics CDMO Players by Market Share
7.3 Asian CDMO Players by Current Capacity
7.4 Global CDMO Players: Key Developments


8. Company Profiles

8.1 Catalent Pharma Solutions Inc.
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy

8.2 Samsung Biologics Co. Ltd.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy

8.3 WuXi AppTec
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy

8.4 Boehringer Ingelheim
8.4.1 Business Overview
8.4.2 Net Sales by Businesses
8.4.3 Business Strategy

8.5 WuXi Biologics (Cayman) Inc.
8.5.1 Business Overview
8.5.2 Operating Regions
8.5.3 Business Strategy

8.6 Jubilant Pharmova Limited
8.6.1 Business Overview
8.6.2 Operating Segments

8.7 Lonza Group AG
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy

8.8 Siegfried Holding AG
8.8.1 Business Overview
8.8.2 Net Sales by Product Group
8.8.3 Business Strategy

8.9 Thermo Fisher Scientific Inc.
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategies

8.10 FUJIFILM Holdings Corporation
8.10.1 Business Overview
8.10.2 Operating Segments
8.10.3 Business Strategy

8.11 Recipharm AB
8.11.1 Business Overview
8.11.2 Business Strategy

8.12 Bushu Pharmaceuticals Ltd.
8.12.1 Business Overview
8.12.2 Business Strategy

8.13 Piramal Group (Piramal Pharma Solutions)
8.13.1 Business Overview
8.13.2 Business Strategy

List of Figures

Figure 1: Benefits Of CDMO
Figure 2: CDMO Segmentation
Figure 3: Global CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 4: Global CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 5: Global CDMO Market by Type; 2023 (Percentage, %)
Figure 6: Global CDMO Market by Product; 2023 (Percentage, %)
Figure 7: Global CDMO Market by Sourcing; 2023 (Percentage, %)
Figure 8: Global CDMO Market by Application; 2023 (Percentage, %)
Figure 9: Global CDMO Market by Region; 2023 (Percentage, %)
Figure 10: Global Chemical Drugs CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 11: Global Chemical Drugs CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 12: Global Biologics CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 13: Global Biologics CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 14: Global API/Bulk Drugs CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 15: Global API/Bulk Drugs CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 16: Global Drug Product Manufacturing (Inc. Dosage & Formulation Development) CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 17: Global Drug Product Manufacturing (Inc. Dosage & Formulation Development) CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 18: Global Packaging CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 19: Global Packaging CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 20: Global In House CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 21: Global In House CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 22: Global Outsourced CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 23: Global Outsourced CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 24: Global Oncology CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 25: Global Oncology CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 26: Global Cardiovascular Disease CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 27: Global Cardiovascular Disease CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 28: Global Diabetes CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 29: Global Diabetes CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 30: Global Hormonal CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 31: Global Hormonal CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 32: Global Glaucoma CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 33: Global Glaucoma CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 34: Global Other CDMO Applications Market By Value; 2019-2023 (US$ Billion)
Figure 35: Global Other CDMO Applications Market By Value; 2024-2029 (US$ Billion)
Figure 36: Asia Pacific CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 37: Asia Pacific CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 38: Asia Pacific CDMO Market by Region; 2023 (Percentage, %)
Figure 39: China CDMO Market by Value, 2019-2023 (US$ Billion)
Figure 40: China CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 41: China CDMO Market by Type; 2023 (Percentage, %)
Figure 42: China Chemical Drugs CDMO Market by Value, 2019-2023 (US$ Billion)
Figure 43: China Chemical Drugs CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 44: China Biologics CDMO Market by Value, 2019-2023 (US$ Billion)
Figure 45: China Biologics CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 46: Japan CDMO Market by Value, 2019-2023 (US$ Billion)
Figure 47: Japan CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 48: India CDMO Market by Value, 2019-2023 (US$ Billion)
Figure 49: India CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 50: Rest of Asia Pacific CDMO Market by Value, 2019-2023 (US$ Billion)
Figure 51: Rest of Asia Pacific CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 52: North America CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 53: North America CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 54: North America CDMO Market by Region; 2023 (Percentage, %)
Figure 55: The US CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 56: The US CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 57: The US CDMO Market by Product; 2023 (Percentage, %)
Figure 58: The US API/Bulk Drugs CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 59: The US API/Bulk Drugs CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 60: The US Drug Product Manufacturing (Inc. Dosage & Formulation Development) CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 61: The US Drug Product Manufacturing (Inc. Dosage & Formulation Development) CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 62: The US Packaging CDMO Market By Value; 2019-2023 (US$ Billion)
Figure 63: The US Packaging CDMO Market By Value; 2024-2029 (US$ Billion)
Figure 64: Canada CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 65: Canada CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 66: Mexico CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 67: Mexico CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 68: Europe CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 69: Europe CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 70: Europe CDMO Market by Region; 2023 (Percentage, %)
Figure 71: Germany CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 72: Germany CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 73: United Kingdom CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 74: United Kingdom CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 75: France CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 76: France CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 77: Rest of Europe CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 78: Rest of Europe CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 79: Rest of the World CDMO Market by Value; 2019-2023 (US$ Billion)
Figure 80: Rest of the World CDMO Market by Value; 2024-2029 (US$ Billion)
Figure 81: Global Percentage of Population Aged 65 Years or Above; 2022, 2030 & 2050 (Percentage, %)
Figure 82: Global Healthcare Expenditure as a Percentage of GDP; 2022 (Percentage, %)
Figure 83: Global Pharmaceutical R&D Expenses; 2017-2026 (US$ Billion)
Figure 84: Global Biotech Sector Annual Capital Raised; 2020-2022 (US$ Million)
Figure 85: Global Biologics Market; 2021-2030 (US$ Billion)
Figure 86: Global Number of Small Molecule Drugs Entering the Development Pipeline; 2016-2028 (Thousand)
Figure 87: Global Biologics CDMO Players by Market Share; 2023 (Percentage,%)
Figure 88: Selected Asian Biologics CDMO Companies by Current Capacity; 2021-2026 (Kilo Litre (kL)
Figure 89: Catalent, Inc. Net Revenue by Segments; 2023 (Percentage, %)
Figure 90: Samsung Biologics Co. Ltd. Revenue by Segments; 2022 (Percentage, %)
Figure 91: WuXi AppTec Revenue by Business Segments; 2022 (Percentage, %)
Figure 92: Boehringer Ingelheim Net Sales by Businesses; 2022 (Percentage, %)
Figure 93: WuXi Biologics (Cayman) Inc. Revenue by Regions; 2022 (Percentage, %)
Figure 94: Jubilant Pharmova Limited Revenue by Segments; 2023 (Percentage, %)
Figure 95: Lonza Group AG Sales by Segments; 2022 (Percentage, %)
Figure 96: Siegfried Holding AG Net Sales by Product Group; 2022 (Percentage, %)
Figure 97: Thermo Fisher Scientific Inc. Revenue by Segment; 2022 (Percentage, %)
Figure 98: FUJIFILM Holdings Corporation Revenue by Segment; 2022 (Percentage, %)
Table 1: CDMO Value Chain Overview
Table 2: Contracts Placed with Pharmaceutical CDMOs; 2020